EU Grants Propel Procarta’s Work on New Antibiotics
By Nuala Moran
Monday, September 30, 2013
LONDON – Procarta Biosystems Ltd. was awarded more than £1 million (US$1.6 million) in two European Union (EU) grants, enabling it to prepare the first of a new generation of antibiotics based on transcription factor decoys for the clinic, and providing a stepping stone to a funding round in which the company aims to raise £10 million.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.